The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, led by researchers at UCL and Newcastle University.

Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's therapies to see if they can slow down or halt the progression of the disease.

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary patterns, and managing stress—can provide symptomatic benefits and ...

For years, dog owners have said their pets know when something’s wrong, whether it’s a bad day, a fever, or something far more serious. Now, new research from the Universities of Bristol and ...

For the second time in recent weeks, the Kennebunk Select Board will need to appoint someone to represent the town on the School Board. On Sept. 18, the Select Board appointed Wayne Sargent to the ...

This first national collaboration will develop a localised neuroprognostication tool and adopt FHIR standards.

Deep within the Cabinet Office on Whitehall, beneath layers of government security, lies the team of civil servants whose job is keeping the nation safe.

A new study finds two neurology drugs cost less without insurance, revealing how complex drug pricing can make medicine more expensive overall.

A Moray community left without a mobile signal for weeks has finally been reconnected. O2 had been slammed for leaving many Portgordon residents high and dry after their mast at the west end of the ...

Osteoporosis occurs so much more commonly in women, for whom medical guidelines recommend universal screening after age 65, that a man who was not a health care professional might not have thought ...